je.st
news
Home
› Premarket Biotech Digest: Portola Insider Buying, Pfizer Advances Avelumab, Cara's Positive Data
Premarket Biotech Digest: Portola Insider Buying, Pfizer Advances Avelumab, Cara's Positive Data
2015-12-11 13:32:22| Biotech - Topix.net
Fullerton Management, a 10% owner in the company, raised its stake in PTLA. The insider purchase does not come as a surprise.
Tags: data
positive
buying
insider
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|